INCY Insider Transactions — Page 11
2,447 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 1,001–1,100; provenance stays internal.
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 14159, L.P. | Director,TenPercentOwner | 2016-02-11 | Purchase | 25,869.0 | $64.46 |
| 667, L.P. | Director,TenPercentOwner | 2016-02-11 | Purchase | 25,869.0 | $64.46 |
| Baker Bros. Advisors (GP) LLC | Director,TenPercentOwner | 2016-02-11 | Purchase | 25,869.0 | $64.46 |
| SWAIN PAULA J | EVP, Human Resources | 2016-01-15 | Sale | 13,531.0 | $76.96 |
| Levy Richard S | EVP, Chief Drug Dev Officer | 2016-01-06 | Sale | 3,937.0 | $101.86 |
| Siegel Eric H. | EVP, General Counsel | 2015-12-10 | Sale | 1,936.0 | $107.96 |
| Levy Richard S | EVP, Chief Drug Dev Officer | 2015-12-07 | Sale | 3,937.0 | $106.18 |
| FRIEDMAN PAUL A | Director | 2015-11-18 | Sale | 38,868.0 | $115.12 |
| FRIEDMAN PAUL A | Director | 2015-11-18 | Sale | 86,132.0 | $115.42 |
| FRIEDMAN PAUL A | Director | 2015-11-17 | Sale | 50,000.0 | $111.37 |
| FRIEDMAN PAUL A | Director | 2015-11-17 | Sale | 42,948.0 | $112.53 |
| FRIEDMAN PAUL A | Director | 2015-11-17 | Sale | 7,052.0 | $112.71 |
| Siegel Eric H. | EVP, General Counsel | 2015-11-10 | Sale | 2,222.0 | $104.86 |
| Levy Richard S | EVP, Chief Drug Dev Officer | 2015-11-06 | Sale | 3,936.0 | $116.51 |
| Wenqing Yao | EVP, Discovery Medicinal and P | 2015-11-03 | Sale | 5,000.0 | $124.75 |
| Wenqing Yao | EVP, Discovery Medicinal and P | 2015-11-03 | Sale | 786.0 | $124.95 |
| Siegel Eric H. | EVP, General Counsel | 2015-10-13 | Sale | 2,222.0 | $101.49 |
| Levy Richard S | EVP, Chief Drug Dev Officer | 2015-10-06 | Sale | 3,937.0 | $122.29 |
| Huber Reid M | EVP, Chief Scientific Officer | 2015-09-21 | Sale | 10,000.0 | $124.29 |
| Siegel Eric H. | EVP, General Counsel | 2015-09-16 | Sale | 2,222.0 | $130.69 |
| Levy Richard S | EVP, Chief Drug Dev Officer | 2015-09-11 | Sale | 4,301.0 | $130.0 |
| Levy Richard S | EVP, Chief Drug Dev Officer | 2015-09-08 | Sale | 3,937.0 | $118.9 |
| Siegel Eric H. | EVP, General Counsel | 2015-08-13 | Sale | 2,222.0 | $107.69 |
| Levy Richard S | EVP, Chief Drug Dev Officer | 2015-08-06 | Sale | 3,936.0 | $111.95 |
| Wenqing Yao | EVP, Discovery Medicinal and P | 2015-07-15 | Sale | 5,000.0 | $119.75 |
| Levy Richard S | EVP, Chief Drug Dev Officer | 2015-07-15 | Sale | 70,217.0 | $120.0 |
| Wenqing Yao | EVP, Discovery Medicinal and P | 2015-07-14 | Sale | 7,850.0 | $114.75 |
| Siegel Eric H. | EVP, General Counsel | 2015-07-14 | Sale | 2,222.0 | $113.61 |
| Levy Richard S | EVP, Chief Drug Dev Officer | 2015-07-06 | Sale | 3,937.0 | $107.0 |
| Daly James M | EVP, Chief Commercial Officer | 2015-06-23 | Sale | 981.0 | $107.84 |
| Daly James M | EVP, Chief Commercial Officer | 2015-06-23 | Sale | 10,710.0 | $108.28 |
| Levy Richard S | EVP, Chief Drug Dev Officer | 2015-06-19 | Sale | 20,000.0 | $108.13 |
| Siegel Eric H. | EVP, General Counsel | 2015-06-12 | Sale | 2,223.0 | $105.31 |
| Levy Richard S | EVP, Chief Drug Dev Officer | 2015-06-08 | Sale | 3,937.0 | $107.58 |
| FRIEDMAN PAUL A | Director | 2015-05-27 | Sale | 16,436.0 | $107.19 |
| FRIEDMAN PAUL A | Director | 2015-05-27 | Sale | 52,696.0 | $107.66 |
| FRIEDMAN PAUL A | Director | 2015-05-26 | Sale | 22,642.0 | $107.15 |
| FRIEDMAN PAUL A | Director | 2015-05-26 | Sale | 50,000.0 | $107.0 |
| FRIEDMAN PAUL A | Director | 2015-05-26 | Sale | 2,358.0 | $107.36 |
| FRIEDMAN PAUL A | Director | 2015-05-26 | Sale | 50,000.0 | $107.0 |
| FRIEDMAN PAUL A | Director | 2015-05-26 | Sale | 2,619.0 | $107.83 |
| Daly James M | EVP, Chief Commercial Officer | 2015-05-26 | Sale | 981.0 | $106.0 |
| Daly James M | EVP, Chief Commercial Officer | 2015-05-26 | Sale | 11,112.0 | $106.43 |
| FRIEDMAN PAUL A | Director | 2015-05-22 | Sale | 25,000.0 | $107.88 |
| FRIEDMAN PAUL A | Director | 2015-05-22 | Sale | 25,000.0 | $107.75 |
| FRIEDMAN PAUL A | Director | 2015-05-22 | Sale | 15,200.0 | $108.5 |
| FRIEDMAN PAUL A | Director | 2015-05-22 | Sale | 14,392.0 | $108.34 |
| FRIEDMAN PAUL A | Director | 2015-05-21 | Sale | 14,388.0 | $108.92 |
| FRIEDMAN PAUL A | Director | 2015-05-21 | Sale | 8,263.0 | $108.75 |
| Siegel Eric H. | EVP, General Counsel | 2015-05-14 | Sale | 2,222.0 | $104.99 |
| Levy Richard S | EVP, Chief Drug Dev Officer | 2015-05-06 | Sale | 7,412.0 | $99.43 |
| Daly James M | EVP, Chief Commercial Officer | 2015-04-23 | Sale | 14,718.0 | $107.67 |
| Daly James M | EVP, Chief Commercial Officer | 2015-04-23 | Sale | 22,223.0 | $107.67 |
| Wenqing Yao | EVP, Discovery Medicinal and P | 2015-04-17 | Sale | 7,150.0 | $102.04 |
| Siegel Eric H. | EVP, General Counsel | 2015-04-14 | Sale | 1,111.0 | $98.72 |
| Siegel Eric H. | EVP, General Counsel | 2015-04-14 | Sale | 1,111.0 | $98.72 |
| SWAIN PAULA J | EVP, Human Resources | 2015-04-13 | Sale | 16,469.0 | $96.29 |
| Wenqing Yao | EVP, Discovery Medicinal and P | 2015-04-13 | Sale | 14,000.0 | $96.75 |
| Wenqing Yao | EVP, Discovery Medicinal and P | 2015-04-10 | Sale | 9,000.0 | $92.75 |
| Wenqing Yao | EVP, Discovery Medicinal and P | 2015-04-07 | Sale | 5,000.0 | $89.75 |
| Wenqing Yao | EVP, Discovery Medicinal and P | 2015-04-07 | Sale | 5,000.0 | $90.29 |
| Wenqing Yao | EVP, Discovery Medicinal and P | 2015-04-07 | Sale | 3,178.0 | $90.22 |
| Wenqing Yao | EVP, Discovery Medicinal and P | 2015-04-07 | Sale | 1,853.0 | $90.27 |
| Wenqing Yao | EVP, Discovery Medicinal and P | 2015-04-07 | Sale | 5,000.0 | $90.25 |
| Levy Richard S | EVP, Chief Drug Dev Officer | 2015-04-06 | Sale | 25,000.0 | $88.77 |
| Chardonnet Laurent | Other | 2015-03-30 | Sale | 27,776.0 | $93.64 |
| Chardonnet Laurent | Other | 2015-03-30 | Sale | 40,000.0 | $93.64 |
| Chardonnet Laurent | Other | 2015-03-30 | Sale | 46,000.0 | $93.64 |
| Huber Reid M | EVP, Chief Scientific Officer | 2015-03-30 | Sale | 4,263.0 | $93.75 |
| Huber Reid M | EVP, Chief Scientific Officer | 2015-03-30 | Sale | 5,000.0 | $93.67 |
| Huber Reid M | EVP, Chief Scientific Officer | 2015-03-30 | Sale | 7,000.0 | $93.66 |
| Huber Reid M | EVP, Chief Scientific Officer | 2015-03-30 | Sale | 8,000.0 | $93.61 |
| Huber Reid M | EVP, Chief Scientific Officer | 2015-03-30 | Sale | 10,000.0 | $93.67 |
| SWAIN PAULA J | EVP, Human Resources | 2015-03-16 | Sale | 17,500.0 | $89.97 |
| ARIKO BARRY A | Director | 2015-03-12 | Sale | 80,000.0 | $89.27 |
| Siegel Eric H. | EVP, General Counsel | 2015-03-12 | Sale | 1,111.0 | $90.02 |
| Siegel Eric H. | EVP, General Counsel | 2015-03-12 | Sale | 1,111.0 | $89.41 |
| Levy Richard S | EVP, Chief Drug Dev Officer | 2015-03-06 | Sale | 25,000.0 | $89.91 |
| Siegel Eric H. | EVP, General Counsel | 2015-03-05 | Sale | 13,333.0 | $90.0 |
| DE SCHUTTER RICHARD U | DirectorOther | 2015-03-05 | Sale | 7,531.0 | $91.68 |
| DE SCHUTTER RICHARD U | DirectorOther | 2015-03-05 | Sale | 32,469.0 | $92.19 |
| Siegel Eric H. | EVP, General Counsel | 2015-02-25 | Sale | 13,333.0 | $85.0 |
| Daly James M | EVP, Chief Commercial Officer | 2015-02-24 | Sale | 8,334.0 | $81.77 |
| Daly James M | EVP, Chief Commercial Officer | 2015-02-23 | Sale | 2,778.0 | $83.44 |
| ARIKO BARRY A | Director | 2015-02-18 | Sale | 20,000.0 | $78.43 |
| Levy Richard S | EVP, Chief Drug Dev&Medical Of | 2015-02-17 | Sale | 12,000.0 | $76.9 |
| SWAIN PAULA J | EVP, Human Resources | 2015-02-17 | Sale | 17,500.0 | $76.9 |
| FRIEDMAN PAUL A | Director | 2015-02-13 | Sale | 60,000.0 | $74.39 |
| FRIEDMAN PAUL A | Director | 2015-02-13 | Sale | 60,000.0 | $74.25 |
| Levy Richard S | EVP, Chief Drug Dev&Medical Of | 2015-02-06 | Sale | 25,000.0 | $75.11 |
| Siegel Eric H. | EVP, General Counsel | 2015-01-26 | Sale | 1,042.0 | $80.0 |
| Daly James M | EVP, Chief Commercial Officer | 2015-01-23 | Sale | 11,109.0 | $77.68 |
| Siegel Eric H. | EVP, General Counsel | 2015-01-23 | Sale | 11,458.0 | $80.0 |
| Siegel Eric H. | EVP, General Counsel | 2015-01-22 | Sale | 1,042.0 | $77.99 |
| SWAIN PAULA J | EVP, Human Resources | 2015-01-20 | Sale | 17,500.0 | $74.17 |
| Levy Richard S | EVP, Chief Drug Dev&Medical Of | 2015-01-16 | Sale | 12,000.0 | $73.07 |
| Siegel Eric H. | EVP, General Counsel | 2015-01-08 | Sale | 15,626.0 | $75.0 |
| Levy Richard S | EVP, Chief Drug Dev&Medical Of | 2015-01-06 | Sale | 25,000.0 | $71.84 |
| SWAIN PAULA J | EVP, Human Resources | 2015-01-05 | Sale | 17,500.0 | $73.9 |
| Daly James M | EVP, Chief Commercial Officer | 2014-12-23 | Sale | 11,113.0 | $74.43 |